Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Oligomycin A is a polyketide-derived macrolide antibiotic originally isolated from S. diastatochromogenes that has diverse biological activities.1,2,3,4,5 It inhibits mitochondrial F1FO-ATP synthase by binding the FO subunit, preventing proton translocation, and uncoupling electron transport and ATP synthesis.2,3 Oligomycin A reduces the proliferation of K562 leukemia, HCT116 colorectal cancer, and MCF-7 breast cancer cells (IC50s = 0.2, 1, and 0.44 µM, respectively).4,5 It is active against S. fradiae, C. kruesi, and fluconazole-sensitive and -resistant C. albicans (MICs = 0.05, 2, 4, and 32 µg/ml, respectively).5
WARNING This product is not for human or veterinary use.
1. Structure determination of oligomycins A and C. Am. Chem. Soc. 51(22), 4264-4271 (1986).
2. Beyond ATP synthase inhibition: Chemical diversification, bioactivities, and therapeutic potential of oligomycin A. Chem. Biol. Drug Des. 106(4), e70173 (2025).
3. Apoptolidin, a selective cytotoxic agent, is an inhibitor of F0F1-
4. Synthesis and cytotoxicity of oligomycin A derivatives modified in the side chain. Bioorg. Med. Chem. 21(11), 2918-2924 (2013).
5. Synthesis, antimicrobial and antiproliferative properties of epi-